News Articles for Roby Zomer

Argent Biopharma has streamlined its asset acquisition of fellow WA cannabis player AusCann, while another Perth player has been subject to a reverse takeover.

Shares in MGC Pharmaceuticals have risen more than 40 per cent after the WA company revealed first orders for its plant-derived medicinal products in the US.

Biopharma company MGC Pharmaceuticals has proposed to buy an Israeli clinical research business for $6 million in shares.

The strong growth of the medicinal cannabis industry will need to be supported by research for the sector to take the next step.

Admedus has appointed Michael Oswell to the newly created role of vice president, development. Based in the US, Mr Oswell has extensive experience in the medical technology industry.

ASX-listed MGC Pharmaceuticals announced today that is has been awarded a contract to build a medical cannabis production facility in Malta, with a $5 million capital raising set to help fund the project.

Medical cannabis company MGC Pharmaceuticals has locked in a supply agreement that it expects to net about $20 million in annual revenue.

Roby Zomer, founder of MGC Pharmaceuticals, has been appointed chief executive officer. Mr Zomer was its executive director and chief technical officer prior to this appointment.